These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23759245)

  • 1. High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.
    Mu Q; Wang Y; Chen B; Qian W; Meng H; Tong H; Chen F; Ma Q; Ni W; Chen S; Jin J
    Leuk Res; 2013 Aug; 37(8):922-7. PubMed ID: 23759245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia.
    Aly RM; Ghazy HF
    Int J Lab Hematol; 2015 Apr; 37(2):272-8. PubMed ID: 25090928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.
    Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR
    BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
    Radich JP; Kopecky KJ; Boldt DH; Head D; Slovak ML; Babu R; Kirk J; Lee A; Kessler P; Appelbaum F
    Leukemia; 1994 Oct; 8(10):1688-95. PubMed ID: 7934164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia.
    Zhao HZ; Jia M; Luo ZB; Cheng YP; Xu XJ; Zhang JY; Li SS; Tang YM
    Neoplasma; 2016; 63(1):150-7. PubMed ID: 26639245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
    Juric D; Lacayo NJ; Ramsey MC; Racevskis J; Wiernik PH; Rowe JM; Goldstone AH; O'Dwyer PJ; Paietta E; Sikic BI
    J Clin Oncol; 2007 Apr; 25(11):1341-9. PubMed ID: 17312329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
    Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
    Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of IKZF1 gene copy number abnormalities in BCR/ABL-negative B-lineage acute lymphoblastic leukemia in children].
    Zou Y; Liu XM; Zhang L; Chen YM; Guo Y; Chen XJ; Yang WY; Wang SC; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1154-9. PubMed ID: 26575870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression.
    Gupta M; Kumar A; Dabadghao S
    Am J Hematol; 2002 Nov; 71(3):172-6. PubMed ID: 12410571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia.
    Craddock KJ; Chen Y; Brandwein JM; Chang H
    Leuk Res; 2013 Jul; 37(7):759-64. PubMed ID: 23643324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
    Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
    Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of BCR-ABL fusion transcripts with poor prognostic impact among adult ALL patients: report from Pakistan.
    Faiz M; Iqbal QJ; Qureshi A
    Asia Pac J Clin Oncol; 2011 Mar; 7(1):47-55. PubMed ID: 21332651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin 15 in primary adult acute lymphoblastic leukemia.
    Wu S; Fischer L; Gökbuget N; Schwartz S; Burmeister T; Notter M; Hoelzer D; Fuchs H; Blau IW; Hofmann WK; Thiel E
    Cancer; 2010 Jan; 116(2):387-92. PubMed ID: 19924795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.